Topic

Humana

A collection of 1312 issues

How to Get Jakafi (Ruxolitinib) Covered by Humana in Florida: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Jakafi (Ruxolitinib) Covered by Humana in Florida Humana Medicare Advantage plans in Florida cover Jakafi (ruxolitinib) on Tier 5 (specialty tier) with prior authorization required for myelofibrosis, polycythemia vera, and GVHD indications. Your prescriber must submit documentation proving hydroxyurea failure (for PV) or intermediate/high-risk disease status

How to Get Krystexxa (Pegloticase) Covered by Humana in Illinois: Complete Prior Authorization and Appeals Guide

Answer Box: Quick Path to Krystexxa Coverage Yes, Humana covers Krystexxa (pegloticase) in Illinois with prior authorization for chronic refractory gout. You'll need documented failure of allopurinol AND febuxostat at maximum doses for 3+ months each, plus normal G6PD test results. Submit your PA via Humana's

Coding That Helps Get Enhertu (fam-trastuzumab deruxtecan-nxki) Approved with Humana in California: ICD-10, J-Code, and NDC Guide

Quick Answer: Coding for Enhertu (fam-trastuzumab deruxtecan-nxki) Approval Getting Enhertu covered by Humana in California requires precise coding: ICD-10 Z17.31 (HER2-positive status) paired with your cancer diagnosis (C50.-, C16.-, C34.-), J-code J9358 (1 mg units), and NDC 65597-0406-01. Submit prior authorization through Humana's Availity

How to Get Sylvant (Siltuximab) Covered by Humana in Washington: Complete PA Guide and Appeals Process

Answer Box: Getting Sylvant (Siltuximab) Covered by Humana in Washington Humana requires prior authorization for Sylvant (siltuximab) to treat HIV-negative, HHV-8-negative multicentric Castleman disease. Your provider submits the PA request via Humana's provider portal with documentation of failed prior therapies (rituximab, corticosteroids, or chemotherapy), HIV/HHV-8 test results,

How to Get Vanflyta (quizartinib) Covered by Humana in Virginia: Complete Coding, Appeals, and Prior Authorization Guide

Answer Box: Getting Vanflyta (quizartinib) Covered by Humana in Virginia Vanflyta (quizartinib) requires prior authorization on Humana Medicare Advantage plans in Virginia as a non-formulary specialty drug. Your fastest path: Have your oncologist submit PA documentation including FLT3-ITD lab results, baseline EKG, and medical necessity letter via Humana's

How to Get Fabrazyme (Agalsidase Beta) Covered by Humana in California: Prior Authorization Forms, Appeals Timeline, and Success Scripts

Answer Box: Getting Fabrazyme Covered by Humana in California Fabrazyme (agalsidase beta) requires prior authorization from Humana in California. Success depends on three key steps: (1) Submit biochemical confirmation of Fabry disease (alpha-Gal A enzyme deficiency <5% and/or pathogenic GLA mutation), (2) Use CenterWell Specialty Pharmacy or approved

How to Get Garadacimab (Andembry) Covered by Humana in Florida: Formulary Alternatives, Appeals, and Prior Authorization Guide

Answer Box: Getting Garadacimab Covered by Humana in Florida Garadacimab (Andembry) is not on Humana's 2025 formulary, requiring a formulary exception with medical necessity documentation. Your fastest path: (1) Try preferred alternatives like Haegarda or Cinryze first if medically appropriate, (2) Document failure/intolerance to alternatives, then (3)

How to Get Myozyme (alglucosidase alfa) Covered by Humana in New Jersey: Coding, Prior Authorization, and Appeals Guide

Answer Box: Getting Myozyme Covered by Humana in New Jersey Myozyme (alglucosidase alfa) requires prior authorization from Humana Medicare Advantage plans and is covered under Medicare Part B when medically necessary for confirmed Pompe disease. Use ICD-10 code E74.02, HCPCS J0171, and submit PA requests through Humana's

How to Get Filspari (sparsentan) Covered by Humana in Michigan: Complete PA Guide and Appeal Process

Answer Box: Your Path to Filspari Coverage To get Filspari (sparsentan) covered by Humana in Michigan: You need biopsy-proven IgA nephropathy with persistent proteinuria ≥1g/day despite ACE inhibitor/ARB therapy, plus enrollment in the FDA REMS program with quarterly liver function tests. Submit prior authorization through your nephrologist using

How to Get Keytruda (Pembrolizumab) Covered by Humana in New York: Complete PA Guide and Appeal Scripts

Answer Box: Getting Keytruda (Pembrolizumab) Covered by Humana in New York Humana Medicare Advantage plans require prior authorization (PA) for Keytruda, covering it as a Part B medical benefit at 80% after deductible. You'll need FDA-approved biomarker testing (PD-L1, MSI-H, or TMB-H), staging documentation, and medical necessity letters.